Correlation between immunological parameters and cutaneous manifestations of systemic lupus erythematosus.
D000906:Antibodies / Q000032:analysis*; D003165:Complement System Proteins / Q000032:analysis; D004247:DNA; D005455:Fluorescent Antibody Technique; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D009504:Neutrophils; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011863:Radioimmunoassay; D012008:Recurrence; D012075:Remission, Spontaneous; D012867:Skin / Q000276:immunology* / Q000473:pathology; D012877:Skin Manifestations; D005719:gamma-Globulins / Q000032:analysis
D000906:Antibodies; D005719:gamma-Globulins; D003165:Complement System Proteins; D004247:DNA; D011241:Prednisone